← Back to news
3D Printing Industry ·

Medical growth and defense demand power Materialise Q2 as software slows

Medical growth and defense demand power Materialise Q2 as software slows

Quick Summary

• Belgian technology company Materialise has raised its full-year profit outlook after posting second-quarter 2026 revenue above EUR 70 million, with growth in medical devices and a rebound in aerospace and defense manufacturing more than offsetting a softer software business. The company, listed on Euronext and NASDAQ under MTLS, now expects Adjusted EBIT of 12,000 to…

Additional Context

Belgian technology company Materialise has raised its full-year profit outlook after posting second-quarter 2026 revenue above EUR 70 million, with growth in medical devices and a rebound in aerospace and defense manufacturing more than offsetting a softer software business.

The company, listed on Euronext and NASDAQ under MTLS, now expects Adjusted EBIT of 12,000 to 14,000 kEUR for 2026, up from the previously communicated range of 10,000 to 12,000 kEUR. Revenue guidance of 273,000 to 283,000 kEUR was left unchanged, even though Materialise has since completed the sale of two business lines that contributed to its top line. CEO Brigitte de Vet-Veithen said the company is “fully absorbing the unfavorable revenue impact of the RapidFit and Eyewear divestments.”

For the quarter ending June

Read original on 3D Printing Industry

Related Stories